939 related articles for article (PubMed ID: 18180426)
1. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.
Cannon TD; Cadenhead K; Cornblatt B; Woods SW; Addington J; Walker E; Seidman LJ; Perkins D; Tsuang M; McGlashan T; Heinssen R
Arch Gen Psychiatry; 2008 Jan; 65(1):28-37. PubMed ID: 18180426
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.
Seidman LJ; Giuliano AJ; Meyer EC; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Christensen BK; Hawkins K; Heaton R; Keefe RS; Heinssen R; Cornblatt BA;
Arch Gen Psychiatry; 2010 Jun; 67(6):578-88. PubMed ID: 20530007
[TBL] [Abstract][Full Text] [Related]
3. Predictive validity of clinical variables in the "at risk" for psychosis population: international comparison with results from the North American Prodrome Longitudinal Study.
Thompson A; Nelson B; Yung A
Schizophr Res; 2011 Mar; 126(1-3):51-7. PubMed ID: 21035313
[TBL] [Abstract][Full Text] [Related]
4. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study.
Ruhrmann S; Schultze-Lutter F; Salokangas RK; Heinimaa M; Linszen D; Dingemans P; Birchwood M; Patterson P; Juckel G; Heinz A; Morrison A; Lewis S; von Reventlow HG; Klosterkötter J
Arch Gen Psychiatry; 2010 Mar; 67(3):241-51. PubMed ID: 20194824
[TBL] [Abstract][Full Text] [Related]
5. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
[TBL] [Abstract][Full Text] [Related]
6. An Individualized Risk Calculator for Research in Prodromal Psychosis.
Cannon TD; Yu C; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Heinssen R; Jeffries CD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Kattan MW
Am J Psychiatry; 2016 Oct; 173(10):980-988. PubMed ID: 27363508
[TBL] [Abstract][Full Text] [Related]
7. Checking the predictive accuracy of basic symptoms against ultra high-risk criteria and testing of a multivariable prediction model: Evidence from a prospective three-year observational study of persons at clinical high-risk for psychosis.
Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
Eur Psychiatry; 2017 Sep; 45():27-35. PubMed ID: 28728092
[TBL] [Abstract][Full Text] [Related]
8. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample.
Miller TJ; Zipursky RB; Perkins D; Addington J; Woods SW; Hawkins KA; Hoffman R; Preda A; Epstein I; Addington D; Lindborg S; Marquez E; Tohen M; Breier A; McGlashan TH
Schizophr Res; 2003 May; 61(1):19-30. PubMed ID: 12648732
[TBL] [Abstract][Full Text] [Related]
9. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome.
Walder DJ; Holtzman CW; Addington J; Cadenhead K; Tsuang M; Cornblatt B; Cannon TD; McGlashan TH; Woods SW; Perkins DO; Seidman LJ; Heinssen R; Walker EF
Schizophr Res; 2013 Mar; 144(1-3):43-50. PubMed ID: 23340377
[TBL] [Abstract][Full Text] [Related]
10. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
[TBL] [Abstract][Full Text] [Related]
11. Multivariate prediction of emerging psychosis in adolescents at high risk for schizophrenia.
Shah J; Eack SM; Montrose DM; Tandon N; Miewald JM; Prasad KM; Keshavan MS
Schizophr Res; 2012 Nov; 141(2-3):189-96. PubMed ID: 23010485
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
[TBL] [Abstract][Full Text] [Related]
13. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study.
Woods SW; Addington J; Cadenhead KS; Cannon TD; Cornblatt BA; Heinssen R; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; McGlashan TH
Schizophr Bull; 2009 Sep; 35(5):894-908. PubMed ID: 19386578
[TBL] [Abstract][Full Text] [Related]
14. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group.
Yung AR; Phillips LJ; Yuen HP; Francey SM; McFarlane CA; Hallgren M; McGorry PD
Schizophr Res; 2003 Mar; 60(1):21-32. PubMed ID: 12505135
[TBL] [Abstract][Full Text] [Related]
15. Early prodromal symptoms can predict future psychosis in familial high-risk youth.
Tandon N; Montrose D; Shah J; Rajarethinam RP; Diwadkar VA; Keshavan MS
J Psychiatr Res; 2012 Jan; 46(1):105-10. PubMed ID: 22056319
[TBL] [Abstract][Full Text] [Related]
16. Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis: A Joint Modeling Approach.
Worthington MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Lympus CA; Mathalon DH; Perkins DO; Stone WS; Walker EF; Woods SW; Zhao Y; Cannon TD
JAMA Psychiatry; 2023 Oct; 80(10):1017-1025. PubMed ID: 37531131
[TBL] [Abstract][Full Text] [Related]
17. Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis.
Buchy L; Perkins D; Woods SW; Liu L; Addington J
Schizophr Res; 2014 Jul; 156(2-3):277-80. PubMed ID: 24837058
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features.
Yung AR; Phillips LJ; Yuen HP; McGorry PD
Schizophr Res; 2004 Apr; 67(2-3):131-42. PubMed ID: 14984872
[TBL] [Abstract][Full Text] [Related]
19. Prediction of functional outcome in individuals at clinical high risk for psychosis.
Carrión RE; McLaughlin D; Goldberg TE; Auther AM; Olsen RH; Olvet DM; Correll CU; Cornblatt BA
JAMA Psychiatry; 2013 Nov; 70(11):1133-42. PubMed ID: 24006090
[TBL] [Abstract][Full Text] [Related]
20. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
